Voloridge Investment Management
MRVI icon

Voloridge Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Voloridge Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-392,492
Closed -$2.57M – 1288
2023
Q4 		$2.57M Buy
+392,492
New +$2.54M 0.01% 773
2023
Q3 		– Sell
-650,296
Closed -$8.08M – 1526
2023
Q2 		$8.08M Buy
650,296
+14,529
+2% +$196K 0.04% 524
2023
Q1 		$8.91M Buy
635,767
+283,685
+81% +$4.07M 0.04% 481
2022
Q4 		$5.04M Buy
+352,082
New +$5.54M 0.03% 636
2022
Q1 		– Sell
-155,021
Closed -$6.5M – 1586
2021
Q4 		$6.5M Sell
155,021
-245,355
-61% -$9.94M 0.04% 621
2021
Q3 		$19.6M Buy
400,376
+302,351
+308% +$14.7M 0.13% 212
2021
Q2 		$4.09M Buy
+98,025
New +$3.8M 0.03% 714

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Voloridge Investment Management's MRVI Position: Q1 2024 in Review

Voloridge Investment Management sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 392,492 shares — an estimated $2.57M sold.

Voloridge Investment Management first reported a position in MRVI in Q2 2021 and held it in 7 quarters. The position peaked at $19.6M in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Voloridge Investment Management reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 392,492 Maravai LifeSciences shares in Q1 2024, an estimated $2.57M.
  • Voloridge Investment Management first reported a position in Maravai LifeSciences in Q2 2021 and held it in 7 quarters.
  • Voloridge Investment Management's Maravai LifeSciences position peaked at $19.6M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.